Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00528853 · ClinicalTrials.gov registry record
Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation
A clinical trial of Bronchiolitis Obliterans Syndrome, sponsored by University of Chicago.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT00528853 is a study of Bronchiolitis Obliterans Syndrome that has completed, run by University of Chicago. The registered enrollment target is 10 participants, below the 120-participant average among 5 other Bronchiolitis Obliterans Syndrome trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00528853, a study of Bronchiolitis Obliterans Syndrome, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
A major source of graft failure and dysfunction in lung transplantation is known to be bronchiolitis obliterans (BO)and its clinical correlate called bronchiolitis obliterans syndrome(BOS). In fact, BOS is the leading cause of death in lung recipients beyond one year post transplant. Currently, our ability to assess lung injury after transplant is less than ideal. The purpose of this study is to use new computerized tomography(CT) technology, specifically , 64 bit acquisition, to detect and predict the onset of lung injuries, with the hope of finding better therapies that currently exist.
Conditions Studied
Study Locations (1)
Illinois
- The University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-08 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00528853
The ClinicalTrials.gov registry entry for NCT00528853 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 120-participant average among 5 other Bronchiolitis Obliterans Syndrome trials with a reported enrollment target (92% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bronchiolitis Obliterans Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT00528853 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00528853 about?
NCT00528853 is a clinical study titled "Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation". A major source of graft failure and dysfunction in lung transplantation is known to be bronchiolitis obliterans (BO)and its clinical correlate called bronchiolitis obliterans syndrome(BOS). In fact, BOS is the leading cause of death in lung recipients beyond one year post transplant. Currently, our ...
What is the current status of trial NCT00528853?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2007-08. Estimated completion is 2009-12.
What conditions does trial NCT00528853 study?
This clinical trial studies the following conditions: Bronchiolitis Obliterans Syndrome.
Who is sponsoring clinical trial NCT00528853?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00528853 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchiolitis Obliterans Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RECRUITING · Phase 2
-
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
RECRUITING
-
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
RECRUITING · Phase 2
-
Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
ACTIVE NOT RECRUITING · Phase 1
-
Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.